| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.027 | 0.7 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.7 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.021 | 0.7 |
| mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |